These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11019929)

  • 1. Antidepressant selection: proceedings from a TCA/SSRI Concensus Conference.
    Mendlewicz J; Lecrubier Y
    Acta Psychiatr Scand Suppl; 2000; 403():5-8. PubMed ID: 11019929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the use of SSRIs reduce medical care utilization and expenditures?
    Chung S
    J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of severe depression: is there an efficacy gap between SSRI and TCA antidepressant generations?
    Nierenberg AA
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():55-9; discussion 60-1, 98-100. PubMed ID: 7961543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant use patterns in clinical practices: comparisons among tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Donoghue J
    Acta Psychiatr Scand Suppl; 2000; 403():57-61. PubMed ID: 11019936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
    Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
    Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
    Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
    Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Zohar J; Westenberg HG
    Acta Psychiatr Scand Suppl; 2000; 403():39-49. PubMed ID: 11019934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
    Perry PJ
    J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-prescribing of SSRIs and TCAs in Australia: how often does it occur and who is doing it?
    McManus P; Mant A; Mitchell P; Birkett D; Dudley J
    Br J Clin Pharmacol; 2001 Jan; 51(1):93-8. PubMed ID: 11167670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
    Anderson IM
    J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tricyclic antidepressants and selective serotonin reuptake inhibitors: use during pregnancy, in children/adolescents and in the elderly.
    Emslie G; Judge R
    Acta Psychiatr Scand Suppl; 2000; 403():26-34. PubMed ID: 11019932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study.
    Lee YC; Lin CH; Lin MS; Lin JW; Chang CH; Lai MS
    J Clin Psychopharmacol; 2013 Dec; 33(6):782-9. PubMed ID: 24091857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia.
    McManus P; Mant A; Mitchell P; Dudley J
    Aust N Z J Psychiatry; 2004 Jun; 38(6):450-4. PubMed ID: 15209838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.
    Hylan TR; Crown WH; Meneades L; Heiligenstein JH; Melfi CA; Croghan TW; Buesching DP
    J Affect Disord; 1998 Jan; 47(1-3):71-9. PubMed ID: 9476746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for and outcome of antidepressant medication in a general population: a prescription database and medical record study, in Jämtland county, Sweden, 1995.
    Henriksson S; Boëthius G; Håkansson J; Isacsson G
    Acta Psychiatr Scand; 2003 Dec; 108(6):427-31. PubMed ID: 14616223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effectiveness of newer and older antidepressants appears mediated by an age effect on the phenotypic expression of depression.
    Parker G
    Acta Psychiatr Scand; 2002 Sep; 106(3):168-70. PubMed ID: 12197852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year costs of second-line therapies for depression.
    Sullivan EM; Griffiths RI; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    J Clin Psychiatry; 2000 Apr; 61(4):290-8. PubMed ID: 10830151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
    Griffiths RI; Sullivan EM; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    Pharmacoeconomics; 1999 May; 15(5):495-505. PubMed ID: 10537966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic outcomes associated with tricyclic antidepressant and selective serotonin reuptake inhibitor treatments for depression.
    Crown WH
    Acta Psychiatr Scand Suppl; 2000; 403():62-6. PubMed ID: 11019937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database.
    Isacsson G; Boëthius G; Henriksson S; Jones JK; Bergman U
    J Affect Disord; 1999 Apr; 53(1):15-22. PubMed ID: 10363662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.